Home/Products
Products & Pipeline
APIs chosen for chemistry that rewards process depth.
Twelve molecules across six therapeutic areas — each with its own page. Development stage and regulatory status are confirmed per molecule on enquiry.
01 Therapeutic focus
Where we concentrate.
Cardiovascular
2 molecules
Rosuvastatin, Ticagrelor
Oncology
2 molecules
Endoxifen, Relugolix
Urology
3 molecules
Mirabegron, Vibegron, Silodosin
Anti-infectives
2 molecules
Levonadifloxacin, Omadacycline
Metabolic
2 molecules
Roxadustat, Resmetirom
Immunology
1 molecule
Tofacitinib
02 Full portfolio
Filter the molecules.
| API | Therapeutic area | Drug class | Documentation |
|---|---|---|---|
| Rosuvastatin | Cardiovascular | HMG-CoA reductase inhibitor (statin) | docs on request |
| Ticagrelor | Cardiovascular | P2Y12 platelet aggregation inhibitor | docs on request |
| Endoxifen | Oncology | active metabolite of tamoxifen (SERM) | docs on request |
| Relugolix | Oncology | oral GnRH receptor antagonist | docs on request |
| Mirabegron | Urology | beta-3 adrenergic receptor agonist | docs on request |
| Vibegron | Urology | beta-3 adrenergic receptor agonist | docs on request |
| Silodosin | Urology | selective alpha-1A adrenoceptor antagonist | docs on request |
| Levonadifloxacin | Anti-infectives | benzoquinolizine fluoroquinolone antibiotic | docs on request |
| Omadacycline | Anti-infectives | aminomethylcycline (tetracycline-class) antibiotic | docs on request |
| Roxadustat | Metabolic | HIF prolyl-hydroxylase (HIF-PH) inhibitor | docs on request |
| Resmetirom | Metabolic | thyroid hormone receptor-beta (THR-β) agonist | docs on request |
| Tofacitinib | Immunology | Janus kinase (JAK) inhibitor | docs on request |
Note for Lewens: split into Commercial vs Development pipeline and populate CAS, formula, grade, DMF/CEP and registrations per molecule once validated by Regulatory.
03 Not on the list?
Ask about a molecule we haven't published.
Much of our work is confidential. If you're evaluating a molecule that isn't shown here, that's exactly the kind of programme we're set up for.
Enquiry
Request documentation
Specs, samples or DMF/CEP status — under NDA where needed.
04 Questions
Product FAQs.
What APIs does Lewens manufacture?
Lewens develops and manufactures APIs across cardiovascular, oncology, urology, anti-infective, metabolic and immunology areas — including Rosuvastatin, Ticagrelor, Endoxifen, Relugolix, Mirabegron, Vibegron, Silodosin, Levonadifloxacin, Omadacycline, Roxadustat, Resmetirom and Tofacitinib.
How do I request specifications or a DMF?
Specifications, samples and regulatory documentation, including DMF/CEP status, are available on request under confidentiality. Send the molecule and requirement to business development.
Does Lewens supply regulated and emerging markets?
Yes — Lewens supplies customers in India and international markets, with growing coverage of regulated and emerging markets.